With 1.02 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.13 million shares. The 52-week range on RXO shows that it touched its highest point at $32.82 and its lowest point at $18.75 during that stretch. It currently has a 1-year price target of $22.47. Beta for the stock currently stands at 1.38.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RXO was up-trending over the past week, with a rise of 3.69%, but this was down by -14.12% over a month. Three-month performance dropped to -21.24% while six-month performance fell -25.42%. The stock gained 0.56% in the past year, while it has lost -9.19% so far this year. A look at the trailing 12-month EPS for RXO yields -2.12 with Next year EPS estimates of 0.66. For the next quarter, that number is -0.01. This implies an EPS growth rate of 146.50% for this year and 124.63% for next year.
Float and Shares Shorts:
At present, 162.52 million RXO shares are outstanding with a float of 157.62 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for RXO since 25 analysts follow the stock currently. There are 13 analysts who recommend BUY ratings, while 3 suggest SELL ratings. Of the remaining analysts, 8 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.13412 being high and $0.0958 being low. For RXO, this leads to a yearly average estimate of $0.11496.
